NeuroSense Therapeutics Ltd.

1.70 USD
-0.10 (-5.56%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NeuroSense Therapeutics Ltd. stock is up 57.41% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 February’s closed higher than January.

About NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd. focuses on discovering and developing treatments for debilitating neurodegenerative diseases in Israel. Its lead product candidate is PrimeC, a novel oral formulation for the treatment of amyotrophic lateral sclerosis.